Brian Grazer
Sage Grazer
United States
2021

Imagine Entertainment

Brian
Grazer

Cofounder / Chairman

Grazer and fellow Imagine chief Ron Howard engaged in a round of buyout talks in the summer of 2021 with international banks, a Middle Eastern sovereign wealth fund and former Disney execs Kevin Mayer and Tom Staggs (armed with $2 billion in capital from Blackstone Group). There were no immediate takers for the 36-year-old prodco, which had a price tag of $800 million to $825 million, and so Grazer went about business as usual, closing a pod producing deal with Noor Alfallah and Remi Alfallah, executive producing series including “Dan Brown’s The Lost Symbol” (Peacock), “The Ms. Pat Show” (BET+) and “Swagger” (Apple TV+) and producing films including Lin-Manuel Miranda’s “Tick, Tick… Boom!” (Netflix) and Howard’s “Thirteen Lives.”

Career

  • HILLBILLY ELEGY
  • WU-TANG: AN AMERICAN SAGA
  • REBUILDING PARADISE

Education

  • University of Southern California (CA, USA)

Variety Honors

  • 2017 Variety500 Honoree
  • 2018 Variety500 Honoree
  • 2019 Variety500 Honoree
  • 2020 Variety500 Honoree
Interested in org charts, contact info and more for Brian Grazer

News from Variety

Imagine Entertainment in Talks to Sell Majority Stake to London Investment Firm Centricus

Imagine Entertainment in Talks to Sell Majority Stake to London Investment Firm Centricus

Imagine Entertainment is in negotiations to sell a majority stake in the production banner headed by Ron Howard and Brian Grazer to London-based investment firm Centricus Asset Management Ltd.The talks were first reported by the The Wall Street Journal. The negotiations are accelerating but a source close to the situation cautions there's still no certainty that a deal will come to fruition. The discussions under way with Centricus are said to value Imagine Entertainment, one of Hollywood's largest independent content...

MORE NEWS

Want more information on Brian Grazer?

Sign up for a free trial to view Brian's contact info, company details, production deals, & more